December 2, 2022 - 13:00 GMT
From the European Society of Medical Oncology (ESMO) 2022 Conference in Paris, a roundtable discussion on the clinical impact of Comprehensive Genomic Profiling and how this diagnostic tool will drive the future of personalised healthcare. Three patient case studies are presented about the clinical utility of genomics in oncology: one about prostate cancer; one with a focus on HRD detection and diagnostics; one about liquid biopsy.